Evidence map›Paper›PMID 25550697›Full record

ArticleImmune network2014

Characterization of Proinflammatory Responses and Innate Signaling Activation in Macrophages Infected with Mycobacterium scrofulaceum.

Ki-Hye Kim, Tae-Sung Kim, Joy G Lee, Jeong-Kyu Park, Miso Yang, Jin-Man Kim, Eun-Kyeong Jo, Jae-Min Yuk

Open access · hybridAbstract read
In one paragraph

Article in Immune network, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
3.2field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Ginsenoside Rc fromJournal of ginseng research · 2017
    Article
  4. Journal of ginseng research · 2017
    Article
  5. Pyrrole-Derivative of Chalcone, (Biomolecules & therapeutics · 2016
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 3 countries.

Ki-Hye KimCenter of Inflammation, Infection & Immunity, Institute for Biomedical Sciences, Georgia State University, Atlanta, GA, USA.
Tae-Sung KimDepartment of Microbiology, Chungnam National University School of Medicine, Daejeon 301-747, Korea. ; Infection Signaling Network Research Center, Chungnam National University School of Medicine, Daejeon 301-747, Korea.
Joy G LeeDepartment of Microbiology, Chungnam National University School of Medicine, Daejeon 301-747, Korea. ; Infection Signaling Network Research Center, Chungnam National University School of Medicine, Daejeon 301-747, Korea.
Jeong-Kyu ParkDepartment of Microbiology, Chungnam National University School of Medicine, Daejeon 301-747, Korea. ; Infection Signaling Network Research Center, Chungnam National University School of Medicine, Daejeon 301-747, Korea.
Miso YangDepartment of Microbiology, Chungnam National University School of Medicine, Daejeon 301-747, Korea. ; Infection Signaling Network Research Center, Chungnam National University School of Medicine, Daejeon 301-747, Korea.
Jin-Man KimInfection Signaling Network Research Center, Chungnam National University School of Medicine, Daejeon 301-747, Korea. ; Department of Pathology, Chungnam National University School of Medicine, Daejeon 301-747, Korea.
Eun-Kyeong JoDepartment of Microbiology, Chungnam National University School of Medicine, Daejeon 301-747, Korea. ; Infection Signaling Network Research Center, Chungnam National University School of Medicine, Daejeon 301-747, Korea.
Jae-Min YukDepartment of Infection Biology, Chungnam National University School of Medicine, Daejeon 301-747, Korea. ; Infection Signaling Network Research Center, Chungnam National University School of Medicine, Daejeon 301-747, Korea.
Chungnam National University · KRGeorgia State University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mycobacterium scrofulaceum is an environmental and slow-growing atypical mycobacterium. Emerging evidence suggests that M. scrofulaceum infection is associated with cervical lymphadenitis in children and pulmonary or systemic infections in immunocompromised adults. However, the nature of host innate immune responses to M. scrofulaceum remains unclear. In this study, we examined the innate immune responses in murine bone marrow-derived macrophages (BMDMs) infected with different M. scrofulaceum strains including ATCC type strains and two clinically isolated strains (rough and smooth types). All three strains resulted in the production of proinflammatory cytokines in BMDMs mediated through toll-like receptor-2 and the adaptor MyD88. Activation of MAPKs (extracellular signal-regulated kinase 1/2, and p38, and c-Jun N-terminal kinase) and nuclear receptor (NF)-κB together with intracellular reactive oxygen species generation were required for the expression of proinflammatory cytokines in BMDMs. In addition, the rough morphotypes of M. scrofulaceum clinical strains induced higher levels of proinflammatory cytokines, MAPK and NF-κB activation, and ROS production than other strains. When mice were infected with different M. scrofulaceum strains, those infected with the rough strain showed the greatest hepatosplenomegaly, granulomatous lesions, and immune cell infiltration in the lungs. Notably, the bacterial load was higher in mice infected with rough colonies than in mice infected with ATCC or smooth strains. Collectively, these data indicate that rough M. scrofulaceum induces higher inflammatory responses and virulence than ATCC or smooth strains.

Indexed as

MAPKsMycobacterium scrofulaceumMyD88Nuclear receptor-κBProinflammatory cytokinesTLR

Identifiers

PMID25550697
PMCPMC4275388
OpenAlexW1981686728

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.